Coalition Against Childhood Cancer

Recent papers from Coalition Against Childhood Cancer

1. A global study of novel agents in paediatric and adolescent relapsed and refractory B-cell non-Hodgkin lymphoma (Glo-BNHL): protocol for an adaptive international platform clinical trialBMC Cancer · 2026
2. Bridging the Gap in Neuroblastoma Care: Consensus‐Based Statements With Recommendations for Improved Patient and Caregiver ExperiencesPediatric Blood & Cancer · 2026
3. Disclosure of Family Cancer History in Black Families With Breast and Ovarian CancerCancer Nursing · 2026
4. Assessing patient-reported outcomes (PROs) in paediatric oncology research: Which PRO would a pro pick, if a pro was picking PROs?EJC Paediatric Oncology · 2025
5. Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationEuropean Journal of Cancer · 2025
6. Stakeholder Perspectives on Randomized Clinical Trials for Children With Poor-Prognosis CancersJAMA Network Open · 2024
7. The Crucial Role of Patient Advocates in Pediatric Oncology Research—Insights From ACCELERATEJAMA Pediatrics · 2024
8. Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancerEuropean Journal of Cancer · 2024
9. Combination Early-Phase Trials of Anticancer Agents in Children and AdolescentsJournal of Clinical Oncology · 2023
10. Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomasEuropean Journal of Cancer · 2022
11. A systematic literature review to identify ethical, legal, and social responsibilities of nonprofit organizations when funding clinical trials in pediatric cancerPediatric Blood & Cancer · 2022
12. Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignanciesEuropean Journal of Cancer · 2021
13. Bromodomain and extra-terminal inhibitors—A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children—ACCELERATEEuropean Journal of Cancer · 2021
14. Integrative Systems Praxis for Implementation Research (INSPIRE): An Implementation Methodology to Facilitate the Global Elimination of Cervical CancerCancer Epidemiology Biomarkers & Prevention · 2020
15. In vivo enrichment of genetically manipulated platelets for murine hemophilia B gene therapyJournal of Cellular Physiology · 2020
16. Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysisInternational Journal of Cancer · 2018
17. Is Proflavine Exposure Associated with Disease Progression in Women with Cervical Dysplasia? A Brief ReportPhotochemistry and Photobiology · 2018
18. Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21–39 YearsCancer Prevention Research · 2018
19. The Cost-Effectiveness of Visual Triage of Human Papillomavirus–Positive Women in Three Low- and Middle-Income CountriesCancer Epidemiology Biomarkers & Prevention · 2017
20. Cervical Precancer and Cancer Risk by Human Papillomavirus Status and Cytologic Interpretation: Implications for Risk-Based ManagementCancer Epidemiology Biomarkers & Prevention · 2016